Sign inJoin waitlistJoin the waitlist

Amy Zhou

Associate Program Director, Hematology & HFFTP · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Hematology & HFFTP · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2012–2015
Internal Medicine
Emory University
2009–2012
Wayne State University School of Medicine
2005–2009
University of Michigan, Ann Arbor, MI
2001–2005

Research

Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Leukemia · 2019 · 126 citations
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Review · Frontiers in Immunology · 2021 · 97 citations
Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia
Leukemia · 2017 · 88 citations

Stephen Oh
11 papers
BT
Benjamin Tan
2 papers
Elizabeth Brunt
2 papers
Eric Knoche
2 papers
JK
Jesse Keller
2 papers · 1 as a fellow
Kathryn Fowler
2 papers
Manik Amin
2 papers · 1 as a fellow
Tim Kong
2 papers
AD
Alexander Duncan
1 paper
Allen Tindol
1 paper
AA
Amber Afzal
1 paper · 1 as a fellow
Ana Antun
1 paper

Clinical trials

Therapeutic RSK1 Targeting in Myelofibrosis
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
2026–2028
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2021–2022